Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
Breast Care (Basel, Switzerland)|September 2, 2014
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014Volker Hanf, Florian Schütz, Cornelia Liedtke, et al.
Breast Care (Basel, Switzerland)|July 22, 2015
Aromatase Inhibitors in the Prevention of Breast CancerElmar Stickeler, Tanja Fehm, Florian Schütz, et al.
Breast Care (Basel, Switzerland)|September 2, 2014
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014Cornelia Liedtke, Marc Thill, Volker Hanf, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2015Volker Hanf, Florian Schütz, Cornelia Liedtke, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015Cornelia Liedtke, Marc Thill, Volker Hanf, et al.
Breast (Edinburgh, Scotland)|September 3, 2011
Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopyMarc Thill, Kathrin Röder, Klaus Diedrich, et al.
Future Oncology (London, England)|February 23, 2019
Biosimilars: what the oncologist should knowMarc Thill, Nicholas Thatcher, Vladimir Hanes, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status ReportOleg Gluz, Cornelia Kolberg-Liedtke, Frederik Marmé, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 23, 2013
Implication of CYP24A1 splicing in breast cancerChimi Scheible, Marc Thill, Sascha Baum, et al.
Current Opinion in Obstetrics & Gynecology|September 7, 2023
Controversies in axillary management of patients with breast cancer - updates for 2024Nikolas Tauber, Vesna Bjelic-Radisic, Marc Thill, et al.
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
Breast Care (Basel, Switzerland)|September 2, 2014
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014Volker Hanf, Florian Schütz, Cornelia Liedtke, et al.
Breast Care (Basel, Switzerland)|July 22, 2015
Aromatase Inhibitors in the Prevention of Breast CancerElmar Stickeler, Tanja Fehm, Florian Schütz, et al.
Breast Care (Basel, Switzerland)|September 2, 2014
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014Cornelia Liedtke, Marc Thill, Volker Hanf, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2015Volker Hanf, Florian Schütz, Cornelia Liedtke, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015Cornelia Liedtke, Marc Thill, Volker Hanf, et al.
Breast (Edinburgh, Scotland)|September 3, 2011
Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopyMarc Thill, Kathrin Röder, Klaus Diedrich, et al.
Future Oncology (London, England)|February 23, 2019
Biosimilars: what the oncologist should knowMarc Thill, Nicholas Thatcher, Vladimir Hanes, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status ReportOleg Gluz, Cornelia Kolberg-Liedtke, Frederik Marmé, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 23, 2013
Implication of CYP24A1 splicing in breast cancerChimi Scheible, Marc Thill, Sascha Baum, et al.
Current Opinion in Obstetrics & Gynecology|September 7, 2023
Controversies in axillary management of patients with breast cancer - updates for 2024Nikolas Tauber, Vesna Bjelic-Radisic, Marc Thill, et al.
Pageof 17